Demographic data of patients suffering from CVST and Thrombocytopenia following COVID-19 AZ Vaccine
Dear Medicines and Healthcare products Regulatory Agency,
Please provide clarity on the age of the 30+ patients who have been registered as having CVST or other thrombosis-related events with Thrombocytopenia following at least one dose of the COV-19 AstraZeneca (Vaxzevria) Vaccine.
For ease and privacy purposes, please provide the number of patients who were:
20-25 years old
25-30 years old
30-35 years old
35-45 years old
55-60 years old
60+ years old
Please provide clarity as to whether these patients had any underlying health issues.
Yours faithfully,
Maria Imaz (PhD. Cambridge University)
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible.
Please note that we may not respond if your query:
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only
Medicines and Healthcare products Regulatory Agency
10 South Colonnade,
Canary Wharf,
London
E14 4PU
gov.uk/mhra
Stay connected
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC.
The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here.
References
Visible links
1. https://www.gov.uk/government/collection...
Our Ref: FOI 21/344
Dear Maria Imaz,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 6 April 2021.
I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.
If you need to contact us again about this request, please quote the reference number above.
Kind Regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Dear Ms Imaz,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division
Medicines and Healthcare Products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Email: [email address]
Stay connected: mhra.gov.uk/stayconnected
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now